Palladium Partners’s Apyx Medical APYX Stock Holding History

Palladium Partners’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-10,000	Closed	-$24K	–	243
2015 Q1	$24K	Hold	10,000	–	–	﹤0.01%	251
2014 Q4	$37K	Buy	+10,000	New	+$38.9K	﹤0.01%	255
2013 Q4	–	Sell	-5,000	Closed	-$14K	–	261
2013 Q3	$14K	Hold	5,000	–	–	﹤0.01%	457
2013 Q2	$15K	Buy	+5,000	New	+$16.8K	﹤0.01%	457

Other funds holding APYX

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

GMCM

Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Palladium Partners's APYX Position: Q2 2015 in Review

Palladium Partners sold out of Apyx Medical (APYX) in Q2 2015, closing a stake of 10,000 shares — an estimated $24K sold.

Palladium Partners first reported a position in APYX in Q2 2013 and held it in 4 quarters. The position peaked at $37K in Q4 2014. 32 funds tracked by Wall St. Rank hold APYX as of Q2 2015.

Palladium Partners reported no remaining Apyx Medical position as of Q2 2015 after selling out during the quarter.
Palladium Partners sold 10,000 Apyx Medical shares in Q2 2015, an estimated $24K.
Palladium Partners first reported a position in Apyx Medical in Q2 2013 and held it in 4 quarters.
Palladium Partners's Apyx Medical position peaked at $37K in Q4 2014.
32 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2015.

Based on Palladium Partners's 13F filing for Q2 2015, filed 28 Jul 2015.